Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2022-11-23
2023-09-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evning Exposure to Computer Screen Disrupts Sleep, Attention and Biological Rhythms
NCT02957383
Circadian Rhythm Monitoring Study
NCT07336654
Evaluation of SmartSleep Technology for Improving the Efficiency and Restorative Quality of Sleep in Healthy Adults
NCT03911154
Seeing the World Through Assorted Glasses
NCT02483559
The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms
NCT03758768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blue light-blocking glasses
Participants will wear blue light-blocking glasses to evaluate whether sleep behaviors improve.
Blue light-blocking glasses
Participants will be randomly assigned to wear either blue light-blocking glasses or glasses with clear lenses during the second week of the study. During the third week, participants will be assigned to wear the opposite pair of glasses.
Glasses with clear lenses
Participants will wear glasses with clear lenses to serve as the control condition.
Glasses with clear lenses
Non-blue light-blocking glasses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blue light-blocking glasses
Participants will be randomly assigned to wear either blue light-blocking glasses or glasses with clear lenses during the second week of the study. During the third week, participants will be assigned to wear the opposite pair of glasses.
Glasses with clear lenses
Non-blue light-blocking glasses
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Capable of providing one's own informed consent
3. Age 18 to 29 years old
4. Healthy, sighted individuals
5. Own an iOS smartphone (iPhone)
6. Willingness to update smartphone to access the current version of the Screen Time or StayFree application, depending on smartphone operating system
7. Willingness to participate in surveys, wear health monitoring devices, and provide screenshots of their smartphone's screentime application throughout the entire study
Exclusion Criteria
2. Individuals who are blind or wear corrective lenses
3. Taking prescribed medications that affect sleep
4. Recent shift work
5. Sleep disorder diagnosis or any cardiovascular disease
18 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Penn State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Reichenberger
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Reichenberger, MS
Role: PRINCIPAL_INVESTIGATOR
Department of Biobehavioral Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biobehavioral Health Building
University Park, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00019746
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.